Variant report
Variant | nsv160554 |
---|---|
Chromosome Location | chr1:154511036-154512983 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:154511183-154511378 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr1:154511195-154511361 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr1:154511172-154511390 | K562 | blood: | n/a | n/a |
4 | CTCF | chr1:154512806-154512870 | Kidney_OC | kidney: | n/a | n/a |
5 | EP300 | chr1:154511957-154512437 | T-47D | breast: | n/a | n/a |
6 | FOXA1 | chr1:154512016-154512382 | T-47D | breast: | n/a | n/a |
7 | FOXA1 | chr1:154511926-154512448 | T-47D | breast: | n/a | n/a |
8 | FOXA1 | chr1:154511954-154512377 | HepG2 | liver: | n/a | n/a |
9 | FOXA2 | chr1:154512074-154512295 | HepG2 | liver: | n/a | n/a |
10 | GATA3 | chr1:154511966-154512413 | T-47D | breast: | n/a | n/a |
11 | GATA3 | chr1:154511972-154512462 | T-47D | breast: | n/a | n/a |
12 | POLR2A | chr1:154511169-154511311 | K562 | blood: | n/a | n/a |
13 | REST | chr1:154511787-154511922 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | SP1 | chr1:154511761-154512045 | HepG2 | liver: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TDRD10 | TF binding region |
ENSG00000163239 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555868408 | chr1:154511046-154511047 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs59257227 | chr1:154511047-154511048 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs577717721 | chr1:154511057-154511058 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs545285847 | chr1:154511067-154511068 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs373577220 | chr1:154511068-154511069 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs563616750 | chr1:154511069-154511070 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186404973 | chr1:154511100-154511101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549143577 | chr1:154511105-154511106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567825476 | chr1:154511109-154511110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190756951 | chr1:154511128-154511129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113854199 | chr1:154511146-154511147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528558987 | chr1:154511185-154511186 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs11265631 | chr1:154511191-154511192 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs183760153 | chr1:154511229-154511230 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs538662957 | chr1:154511291-154511292 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs188189706 | chr1:154511316-154511317 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs569513068 | chr1:154511329-154511330 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs367849591 | chr1:154511333-154511334 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs536578631 | chr1:154511334-154511335 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs148179718 | chr1:154511365-154511366 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs573524063 | chr1:154511366-154511367 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs141604533 | chr1:154511397-154511398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376172067 | chr1:154511461-154511462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142038703 | chr1:154511500-154511501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12136771 | chr1:154511502-154511503 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs75323106 | chr1:154511504-154511505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577680651 | chr1:154511569-154511570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545012333 | chr1:154511572-154511573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563169887 | chr1:154511580-154511581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555411633 | chr1:154511604-154511605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377116674 | chr1:154511605-154511606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138427579 | chr1:154511639-154511640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542599823 | chr1:154511707-154511708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs57783436 | chr1:154511709-154511710 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs545052311 | chr1:154511753-154511754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528279534 | chr1:154511785-154511786 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs142739387 | chr1:154511862-154511863 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs565059154 | chr1:154511865-154511866 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs532499635 | chr1:154511866-154511867 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs550938168 | chr1:154511872-154511873 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs569197699 | chr1:154511882-154511883 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs183194308 | chr1:154511897-154511898 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548606219 | chr1:154511927-154511928 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs539384449 | chr1:154511929-154511930 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs534411737 | chr1:154511951-154511952 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs112394421 | chr1:154512008-154512009 | Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
47 | rs571347888 | chr1:154512068-154512069 | Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs73023346 | chr1:154512077-154512078 | Weak transcription Strong transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs556909971 | chr1:154512139-154512140 | Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs575131860 | chr1:154512156-154512157 | Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:154492800-154521400 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr1:154494800-154512000 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr1:154497600-154521200 | Weak transcription | Spleen | Spleen |
4 | chr1:154510400-154513600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr1:154511200-154511400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr1:154511400-154511600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:154511400-154511600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr1:154511600-154513200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:154512000-154513600 | Strong transcription | Adipose Nuclei | Adipose |
10 | chr1:154512400-154512600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr1:154512400-154512600 | Active TSS | Pancreas | Pancrea |
12 | chr1:154512400-154513800 | Enhancers | Lung | lung |
13 | chr1:154512600-154516400 | Weak transcription | Pancreas | Pancrea |